OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 16

Showing 16 citing articles:

The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
Yishan Lu, Danyi Ao, Xuemei He, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 6

Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages
Qian Wang, Ian A. Mellis, Anthony Bowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5

Safety and Immunogenicity of Omicron Protein Vaccines in mRNA-Vaccinated Adolescents: A Phase 3, Randomised Trial
Chijioke Bennett, Gordon Chau, Elizabeth Clayton, et al.
Journal of Infection (2025), pp. 106428-106428
Open Access

Neutralizing antibody responses to three XBB protein vaccines in older adults
Guo‐Jian Yang, Mei Lu, Rui-Rui Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion
Wenjing Ruan, Pengyue Gao, Xiao Qu, et al.
EBioMedicine (2025) Vol. 114, pp. 105634-105634
Closed Access

Investigating the FLiRT Variants of COVID-19: Is it An Emerging Concern?
Durre Aden, Sufian Zaheer
Pathology - Research and Practice (2024) Vol. 262, pp. 155542-155542
Closed Access | Times Cited: 4

Beyond COVID-19: the promise of next-generation coronavirus vaccines
Reshma Koolaparambil Mukesh, Claude Kwe Yinda, Vincent J. Munster, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3

SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 3

Tracking KP.2 SARS-CoV-2 Variant in India and the Clinical Profile of KP.2 Cases in Maharashtra, India
Rajesh Karyakarte, Rashmita Das, Varsha Potdar, et al.
Cureus (2024)
Open Access | Times Cited: 1

Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
Roaa Hadi, Abhishek Poddar, Shivakumar Sonnaila, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1794-1794
Open Access | Times Cited: 1

Predictive Assessment of the Antiviral Properties of Imperata cylindrica against SARS‐CoV‐2
Frank Eric Tatsing Foka, Hazel Tumelo Mufhandu
Advances in Virology (2024) Vol. 2024, Iss. 1
Open Access

SARS-CoV-2 and Environmental Changes: The Perfect Storm
Mario Caldarelli, Pierluigi Rio, Vincenzo Giambra, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 11835-11852
Open Access

Safety and Immunogenicity of Omicron Protein Vaccines in mRNA-Vaccinated Adolescents: A Phase 3, Randomised Trial
Chijioke Bennett, Gordon Chau, Elizabeth Clayton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

FLiRTing with danger: The emergence of the KP.2 Omicron variant
Yashu, Shiv Shankar Shukla, Honey Goel, et al.
Asian Pacific Journal of Tropical Medicine (2024)
Open Access

Page 1

Scroll to top